SGO 2018

Study results show that women who carry a BRCA1 mutation have a shorter reproductive lifespan than n

SGO 2018

Everolimus Plus Letrozole May Be Active in Recurrent Endometrial Carcinoma

March 24, 2018

Researchers randomly assigned 74 patients to receive everolimus plus letrozole daily or tamoxifen daily plus medroxyprogesterone daily on alternating weeks.

Socioeconomic status, including education and income level, appears to be tied to prostate-specific

SGO 2018

Affordable Care Act Increased Percentage of Insured Patients With Gynecologic Cancers

Jonathan Goodman, MPhil

March 24, 2018

The impact of the ACA on health insurance access among women diagnosed with a gynecologic cancer was previously unestablished.

Next post in SGO 2018

SGO 2018

Everolimus Plus Letrozole May Be Active in Recurrent Endometrial Carcinoma

Affordable Care Act Increased Percentage of Insured Patients With Gynecologic Cancers

Want to read more?

Pembrolizumab: Cost-Effective for Recurrent, MSI-H Endometrial Cancer